Prestige Consumer Healthcare Inc.
Rating
Updated: Aug 11, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both...
Latest News
8 days ago · zacks.com
PBH or NEOG: Which Is the Better Value Stock Right Now?Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?
12 days ago · seekingalpha.com
Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference TranscriptPrestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
21 days ago · prnewswire.com
Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress TestNational survey commissioned by DenTek, the #1 OTC dental guard brand for nighttime teeth grinding, finds nearly 8 in 10 football fans keep thinking about the game after it ends, with many reporting stress-related behaviors that extend into bedtime. NFL legends Ronde & Tiki Barber join DenTek to encourage fans to recognize when football stress may be affecting more than just game day.
25 days ago · zacks.com
PBH vs. SYK: Which Stock Is the Better Value Option?Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
1 month ago · foxbusiness.com
Nearly 40,000 eye drops recalled nationwide over possible contaminationPrestige Brand Holdings is recalling 39,060 bottles of certain Clear Eyes drops over sterility concerns, according to a Food and Drug Administration report.
1 month ago · seekingalpha.com
Amylyx: Upgraded To Strong Buy On LUCIDITY Outcome, Avexitide, And 2026 CatalystsAmylyx Pharmaceuticals, Inc. is upgraded to Strong Buy after positive phase 3 LUCIDITY results for avexitide in post-bariatric hypoglycemia [PBH]. Avexitide met its primary endpoint, achieving a 55% reduction in severe hypoglycemic events, with strong statistical significance and a favorable safety profile. Key catalysts include an NDA submission for avexitide in PBH by end-2026 and medical data presentation in 2026; expansion into long-acting GLP-1 antagonist AMX0318 is underway.
1 month ago · zacks.com
PBH or SYK: Which Is the Better Value Stock Right Now?Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
1 month ago · marketbeat.com
Premium Brands Q2 Earnings Call HighlightsPremium Brands TSE: PBH said its revised 2026 outlook reflects timing shifts in U.S. customer programs and the exit of a low-margin Ontario facility, rather than a deterioration in the company's underlying operating assumptions.
2 months ago · seekingalpha.com
Prestige Consumer Healthcare Inc. (PBH) Q1 2027 Earnings Call TranscriptPrestige Consumer Healthcare Inc. (PBH) Q1 2027 Earnings Call Transcript
2 months ago · zacks.com
Prestige Consumer Healthcare (PBH) Q1 Earnings and Revenues Surpass EstimatesPrestige Consumer Healthcare (PBH) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.95 per share a year ago.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove PBH